A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT02737332 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Zytiga® (Abiraterone Acetate)
DRUG: SoluMatrix™ (Abiraterone Acetate)

Sponsor

Sun Pharmaceutical Industries Limited